Journal of Clinical Epidemiology
Volume 52, Issue 9 , Pages 875-884 , September 1999

Test-Retest Reliability of the GO-QOL: A Disease-Specific Quality of Life Questionnaire for Patients with Graves' Ophthalmopathy

  • C.B. Terwee

      Affiliations

    • Departments of Clinical Epidemiology and Biostatistics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    • Corresponding Author InformationAddress for correspondence: Ms. C. B. Terwee, Department of Clinical Epidemiology and Biostatistics, J2-218, Academic Medical Center, University of Amsterdam, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands. Tel.: 31-20-566-6880; Fax: 31-20-691-2683
    • ,
  • M.N. Gerding

      Affiliations

    • Departments of Endocrinology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    • ,
  • F.W. Dekker

      Affiliations

    • Departments of Clinical Epidemiology and Biostatistics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    • ,
  • M.F. Prummel

      Affiliations

    • Departments of Endocrinology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    • ,
  • J.P. van der Pol

      Affiliations

    • Departments of Orbital Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    • ,
  • W.M. Wiersinga

      Affiliations

    • Departments of Endocrinology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

,Accepted 30 March 1999.

References 

  1. Bahn RS, Heufelder AE. Pathogenesis of Graves' ophthalmopathy. N Engl J Med. 1993;329:1468–1475
  2. Weetman AP. Thyroid-associated eye disease (Pathophysiology). Lancet. 1991;338:25–28
  3. Guyatt GH, Naylor D, Juniper E, Heyland DK, Jaeschke R, Cook DJ. Users' guides to the medical literature. XII. How to use articles about health-related quality of life. JAMA. 1997;77:1232–1237
  4. Hunt SM. The problem of quality of life. Quality of Life Research. 1997;6:205–212
  5. Leplège A, Hunt S. The problem of quality of life in medicine. JAMA. 1997;278:47–50
  6. Gill TM, Feinstein AR. A critical appraisal of the quality of life measurements. JAMA. 1994;272:619–631
  7. Pinchera A, Wiersinga WM, Glinoer D, et al.  Classification of eye changes of Graves' disease. Thyroid. 1992;2:235–236
  8. Gerding MN, Terwee CB, Dekker FW, Prummel MF, Wiersinga WM. Quality of life in patients with Graves' ophthalmopathy is markedly decreased (Measurement by the Medical Outcome Study instrument). Thyroid. 1997;7:885–889
  9. Testa MA, Simonson DC. Assessment of quality of life outcomes. N Engl J Med. 1996;334:835–840
  10. Guyatt GH, Bombardier C, Tugwell PX. Measuring disease-specific quality of life in clinical trials. CAMJ. 1986;134:889–895
  11. Partick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care. 1989;27:S217–S232
  12. Terwee CB, Dekker FW, Gerding MN, Prummel MF, Wiersinga WM. Development of a disease-specific quality of life questionnaire for patients with Graves' ophthalmopathy. Quality of Life Research. 1997;6:444;(Abstract)
  13. Terwee CB, Gerding MN, Dekker FW, Prummel MF, Wiersinga WM. Development of a disease-specific quality of life questionnaire for patients with Graves' ophthalmopathy (The GO-QOL). Br J Ophthalmol. 1998;82:773–779
  14. Guyatt G, Walter S, Noman G. Measuring change over time (Assessing the usefulness of evaluative instruments). J Chron Dis. 1987;40:171–178
  15. Stewart AL, Hays RD, Ware JE. The MOS Short-form General Health Survey (Reliability and validity in a patient population). Med Care. 1988;26:724–735
  16. Bergner M, Bobbitt RA, Kressel S, Pollard WE, Gilson BS, Morris JR. The Sickness Impact Profile (Conceptual formulation and methodology for the development of a health status measure). Int J Health Serv. 1976;6(Suppl 3):393–415
  17. Werner SC. Modification of the classification of the eye changes in Graves' disease (Recommendations of the ad hoc committee of the American Thyroid Association). J Clin Endocrinol Metab. 1977;44:203–204
  18. Mourits MP, Prummel MF, Wiersinga WM, Koornneef L. Clinical Activity Score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol. 1997;47:9–14
  19. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures. Controlled Clinical Trials. 1991;12:142S–158S
  20. Streiner DL, Normal GR. Health Measurement Scales. A Practical Guide to Their Development and Use. Oxford, UK; New York, NY, USA; Tokyo, Japan: Oxford University Press, 1989.
  21. Kirschner B, Guyatt G. A methodological framework for assessing health indices. J Chron Dis. 1985;38:27–36
  22. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;i:307–317
  23. Müller R, Büttner P. A critical discussion of Intraclass Correlation Coefficients. Stat Med. 1994;13:2465–2476
  24. Shrout PE, Fleiss JL. Intraclass Correlations (Uses in assessing rater reliability). Psychological Bulletin. 1979;86:420–428
  25. Norman GR, Stratford P, Regehr G. Methodological problems in the retrospective computation of responsiveness to change (the lesson of Cronbach). J Clin Epidemiol. 1997;50:869–879
  26. Prummel MF, Mourits MP, Berghout A, Krenning EP, van der Gaag R, Koornneef L, et al. Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy. N Engl J Med. 1989;16:1403–1405
  27. Prummel MF, Mourits MP, Blank L, Berghout A, Koornneef L, Wiersinga WM. Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet. 1993;342:949–954
  28. Kahaly G, Pitz S, Muller-Forell W, Hommel G. Randomized trial of intravenous immunoglobulins versus prednisolone in Graves' ophthalmopathy. Clinical & Experimental Immunology. 1996;106:197–202
  29. Fleiss JL. The Design and Analysis of Clinical Experiments. New York, NY, USA: John Wiley & Sons; 1986;

PII: S0895-4356(99)00069-4

Journal of Clinical Epidemiology
Volume 52, Issue 9 , Pages 875-884 , September 1999

Article Tools

* Image Usage & Resolution